This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Top DuPont-Driven Stocks to Counter Stimulus Uncertainty
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Cigna's Acquisitions, Diversified Businesses to Aid Growth
by Zacks Equity Research
Cigna's (CI) expanded business portfolio and favorable cash flow generation to contribute to the stock's prospects.
Humana Ties Up to Offer Better Healthcare in Colorado Springs
by Zacks Equity Research
Humana (HUM) partners Centura Health in Colorado Springs to dispense high-quality in-network medical care for Humana Medicare Advantage members.
Humana (HUM) Offers Medicare Advantage Health Plans for 2021
by Zacks Equity Research
Humana (HUM) unveils 2021 Medicare product offerings and better benefits in more counties across the nation.
Cigna's 2021 Improved Health Plans to Expand Member Base
by Zacks Equity Research
Cigna's (CI) 2021 health plans with enhanced features will not only expand its presence by 22% in the United States but also provide improved health outcomes.
UnitedHealth Arm Rolls Out Enhanced Health Plans for 2021
by Zacks Equity Research
UnitedHealth Group's (UNH) unit, UnitedHealthcare, reveals cost-effective health plans for 2021. This is likely to expand the company's U.S. footprint.
Humana Ties Up to Provide Improved Healthcare in Chicago
by Zacks Equity Research
Humana (HUM) partners Rush Health to offer in-network medical care in the Chicago region for Humana Medicare Advantage members.
Molina Healthcare to Buy Affinity Health Plan for $380 Million
by Zacks Equity Research
Molina Healthcare (MOH) to purchase Affinity Health Plan's assets to boost its capabilities and enhance its portfolio in the process.
UnitedHealthcare's Health Plan to Aid Kansas City's Employers
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, rolls out a cost-effective health plan to benefit employers in the Kansas City area.
Here's Why You Should Hold Centene (CNC) in Your Portfolio
by Zacks Equity Research
Riding high on rising revenues and strategic initiatives, Centene (CNC) holds potential to reap benefits for investors.
Select Medical Enters Into Joint Venture With Rush University
by Zacks Equity Research
Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.
Humana Ties Up to Provide Improved Medical Care in Ohio
by Zacks Equity Research
Humana (HUM) partners The Ohio State University Wexner Medical Center to provide in-network healthcare for Humana Medicare Advantage members.
The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA
Uncertainty Over Supreme Court Ruling Weighs on Healthcare
by Zacks Equity Research
Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.
5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
Humana (HUM) Ties Up to Boost Medicare Network in New Jersey
by Zacks Equity Research
Humana (HUM) forges partnership with AtlantiCare to enhance its presence in New Jersey as well as provide better healthcare to its members.
Here's Why You Should Retain Cigna Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) is poised for growth, given its continuous efforts to innovate solutions and growing suite of telehealth services.
Here's What Makes UnitedHealth (UNH) an Attractive Stock
by Zacks Equity Research
United Health's (UNH) prolific business profile, strong market share and a reputed brand name poise it well for long-term growth.
Centene Ties Up to Expand Telehealth Services in Rural Areas
by Zacks Equity Research
Centene (CNC) partners with Samsung Electronics America to make telehealth offerings available in rural and underserved areas.
Humana's New Value-Based Care Plans to Better Healthcare
by Zacks Equity Research
Humana's (HUM) enriched value-based care programs are expected to curtail expenses as well as boost quality of healthcare.
UnitedHealthcare, Canopy Health Come Up With New Health Plan
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, expands collaboration with Canopy Health by rolling out a health plan for benefiting people in the Bay Area.
Cigna (CI) Enhances Offerings in the Individual Exchange
by Zacks Equity Research
Cigna's (CI) health plans with enhanced features will not only expand its customer reach by 27% but also strengthen its presence on the individual exchange.
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD
by Zacks Equity Research
Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD
Here's Why You Should Hold Magellan Stock in Your Portfolio
by Zacks Equity Research
Magellan (MGLN) continues to benefit from cost-cutting initiatives and impressive capital position.